We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




New Technique for HPV Research

By Biotechdaily staff writers
Posted on 01 Jul 2005
Cancer researchers have developed a technique that allows cultivation of much larger quantities of human papillomavirus (HPV) than has previously been possible, which should stimulate the search for treatments and vaccines for cervical, head, neck, and some skin cancers. More...


Investigators at the University of Wisconsin (Madison, USA) found a novel way to cope with the life cycle of the virus, which initially infects undifferentiated skin cells. As the undifferentiated cells mature, the virus particle acquires a protein coat for its DNA, and begins to manufacture new particles to infect other undifferentiated cells. Previous methods for growing the virus in tissue culture produced very limited amounts of infectious particles.

The new methodology, described in the June 15, 2005, online edition of the Proceedings of the [U. S.] National Academy of Sciences, was based on the addition of viral DNA and capsid protein molecules to cultures of undifferentiated skin cells. "This new approach offers dramatic advantages,” explained senior author Dr. Paul Ahlquist, professor of virology at the University of Wisconsin. "It increases virus yield over a thousand fold, speeds production ten-fold, and lets us make and test virus mutants that were not possible before.”

This method permits the straightforward generation of infectious particles containing wild type, mutant, or chimeric papillomaviral genomes, overcoming barriers to studying many facets of replication, host interactions, and vaccine and drug development.

New
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
New
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
New
Automatic CLIA Analyzer
Shine i6000
New
Creatinine/eGFR Meter
StatSensor® Creatinine/eGFR Meter
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image

Urine-Based Multi-Cancer Screening Test Receives FDA Breakthrough Device Designation

Early detection across multiple cancers remains a major unmet need in population screening. Non-invasive approaches that can be delivered at scale may broaden access and shift diagnoses to earlier stages.... Read more

Molecular Diagnostics

view channel
Image: The new approach focuses on CpG DNA methylation, a chemical modification of cytosine and guanine bases, using tumor samples to develop a computational model that distinguishes among 21 cancer types (photo credet: 123RF)

Machine Learning Model Uses DNA Methylation to Predict Tumor Origin in Cancers of Unknown Primary

Cancers of unknown primary (CUP) are metastatic malignancies in which the primary site cannot be identified, complicating treatment selection. Many patients consequently receive broad, nonspecific chemotherapy... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.